UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neck Location on the Outer Convexity is a Predictor of Incomplete Occlusion in Treatment with the Pipeline Embolization Device: Clinical and Angiographic Outcomes

American journal of neuroradiology : AJNR, 2021-01, Vol.42 (1), p.119-125

2021

Volltextzugriff (PDF)

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay

British journal of cancer, 2012-05, Vol.106 (10), p.1675-1681

2012

Volltextzugriff (PDF)

Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method

British journal of cancer, 2011-10, Vol.105 (8), p.1197-1202

2011

Volltextzugriff (PDF)

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

British journal of cancer, 2013-09, Vol.109 (6), p.1693-1698

2013

Volltextzugriff (PDF)

Timing of childbirth, capital accumulation, and economic welfare

Oxford economic papers, 2013-04, Vol.65 (2), p.494-522

2013

Volltextzugriff (PDF)

Lymphatic invasion is significantly associated with prognosis in patients with node-negative early luminal breast cancer

Breast (Edinburgh), 2017-03, Vol.32, p.S87-S87

2017

Volltextzugriff (PDF)

Treatment outcomes of stage IIIC breast cancer: a single institutional review

Breast (Edinburgh), 2017-03, Vol.32, p.S67-S67

2017

Volltextzugriff (PDF)

Predictive factors and value of ypN+ after neoadjuvant chemotherapy in clinically lymph node-negative breast cancer

Breast (Edinburgh), 2017-03, Vol.32, p.S92-S92

2017

Volltextzugriff (PDF)

Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells

Oncogene, 2014-01, Vol.33 (4), p.440-448

2014

Volltextzugriff (PDF)

The feasibility of sentinel node biopsy in the previously treated breast

European journal of surgical oncology, 2008-04, Vol.34 (4), p.365-368

2008

Volltextzugriff (PDF)

P325 Lymphedema incidence over time with sentinel lymph node dissection alone of Japanese women

Breast (Edinburgh), 2015-03, Vol.24, p.S138-S138

2015

Volltextzugriff (PDF)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer

British journal of cancer, 2007-08, Vol.97 (5), p.654-658

2007

Volltextzugriff (PDF)

Natural disasters in a two-sector model of endogenous growth

Journal of public economics, 2012-10, Vol.96 (9-10), p.784-796

2012

Volltextzugriff (PDF)

226. Can irradiation suppress multicentric cancers in conserved breast?

European journal of surgical oncology, 2012-09, Vol.38 (9), p.806-807

2012

Volltextzugriff (PDF)

Wants and past knowledge: Growth cycles with emerging industries

Journal of economic dynamics & control, 2012-02, Vol.36 (2), p.220-238

Horii, Ryo

2012

Volltextzugriff (PDF)

Abstract P2-06-02: Breast cancer HER2 epigenetic intratumoral heterogeneity results from lack of HER2 protein translation

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-06-02

2018

Volltextzugriff (PDF)

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer

Oncology letters, 2019-02, Vol.17 (2), p.2177-2186

2019

Volltextzugriff (PDF)

Abstract P1-03-08: Simultaneous analyses of HER2 gene and protein status can more precisely predict pathological complete response (pCR) to neoadjuvant trastuzumab with chemotherapy in primary HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-03-08

2017

Volltextzugriff (PDF)

511 (PB-144) - Clinical significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, in HER2-positive breast cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S150-S150

2018

Volltextzugriff (PDF)

Clinical significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, in HER2-positive breast cancer

European journal of cancer (1990), 2018-04, Vol.92, p.S150

2018

Volltextzugriff (PDF)

Abstract P4-08-29: Lymphatic invasion is an independent risk factor in patients with small node-negative luminal breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-08-29

2019

Volltextzugriff (PDF)

Economic Growth with Imperfect Protection of Intellectual Property Rights

Journal of economics (Vienna, Austria), 2007-01, Vol.90 (1), p.45-85

2007

Volltextzugriff (PDF)

Eribulin mesylate may improve the sensitivity of endocrine therapy in metastatic breast cancer

Annals of oncology, 2016-10, Vol.27, p.vi75-vi75

2016

Volltextzugriff (PDF)

Abstract P4-02-13: The pattern of tumor shrinkage is associated with prognosis in low grade luminal early breast cancer during neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P4-P4-02-13

2016

Volltextzugriff (PDF)

P134 - Treatment outcomes of stage IIIC breast cancer: a single institutional review

Breast (Edinburgh), 2017-03, Vol.32, p.S67-S67

2017

Volltextzugriff (PDF)

1 – 25 von 970

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(763)
Mit Volltextzugriff
(829)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neck Location on the Outer Convexity is a Predictor of Incomplete Occlusion in Treatment with the Pipeline Embolization Device: Clinical and Angiographic Outcomes

Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay

Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

Timing of childbirth, capital accumulation, and economic welfare

Lymphatic invasion is significantly associated with prognosis in patients with node-negative early luminal breast cancer

Treatment outcomes of stage IIIC breast cancer: a single institutional review

Predictive factors and value of ypN+ after neoadjuvant chemotherapy in clinically lymph node-negative breast cancer

Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells

The feasibility of sentinel node biopsy in the previously treated breast

P325 Lymphedema incidence over time with sentinel lymph node dissection alone of Japanese women

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer

Natural disasters in a two-sector model of endogenous growth

226. Can irradiation suppress multicentric cancers in conserved breast?

Wants and past knowledge: Growth cycles with emerging industries

Abstract P2-06-02: Breast cancer HER2 epigenetic intratumoral heterogeneity results from lack of HER2 protein translation

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer

Abstract P1-03-08: Simultaneous analyses of HER2 gene and protein status can more precisely predict pathological complete response (pCR) to neoadjuvant trastuzumab with chemotherapy in primary HER2-positive breast cancer

511 (PB-144) - Clinical significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, in HER2-positive breast cancer

Clinical significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, in HER2-positive breast cancer

Abstract P4-08-29: Lymphatic invasion is an independent risk factor in patients with small node-negative luminal breast cancer

Economic Growth with Imperfect Protection of Intellectual Property Rights

Eribulin mesylate may improve the sensitivity of endocrine therapy in metastatic breast cancer

Abstract P4-02-13: The pattern of tumor shrinkage is associated with prognosis in low grade luminal early breast cancer during neoadjuvant chemotherapy

P134 - Treatment outcomes of stage IIIC breast cancer: a single institutional review

Suchergebnisse filtern